Tonix Pharmaceuticals Holding (TNXP) Current Assets (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Current Assets of $207.2 million for Q1 2026, up 38.51% year-over-year from $149.6 million in Q1 2025, and down 9.48% quarter-over-quarter from $228.9 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Current Assets (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Current Assets history runs 17 years deep, the most recent figure standing at $207.2 million for Q1 2026.
- In Q1 2026, Current Assets rose 38.51% year-over-year to $207.2 million; the TTM figure through Mar 2026 stood at $207.2 million (up 38.51% YoY), while the FY2025 annual figure was $228.9 million, up 92.33% from the prior year.
- Current Assets for Q1 2026 stood at $207.2 million, down from $228.9 million in the prior quarter.
- The five-year high for Current Assets was $228.9 million in Q4 2025, with the low at $25.3 million in Q2 2024.
- The 5-year median for Current Assets is $130.8 million (2022), against an average of $117.8 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets slumped 79.27% in 2023, then soared 467.62% in 2025.
- Tonix Pharmaceuticals Holding's Current Assets stood at $130.8 million in 2022, then plunged by 63.47% to $47.8 million in 2023, then soared by 149.12% to $119.0 million in 2024, then soared by 92.33% to $228.9 million in 2025, then fell by 9.48% to $207.2 million in 2026.
- Business Quant data shows TNXP's Current Assets at $207.2 million in Q1 2026, $228.9 million in Q4 2025, and $208.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 203.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 203.43 Mn |
| Mar 31, 2026 | 207.17 Mn |
| Dec 31, 2025 | 228.88 Mn |
| Sep 30, 2025 | 208.07 Mn |
| Jun 30, 2025 | 143.54 Mn |
| Mar 31, 2025 | 149.57 Mn |
| Dec 31, 2024 | 119.00 Mn |
| Sep 30, 2024 | 50.54 Mn |
| Jun 30, 2024 | 25.29 Mn |
| Mar 31, 2024 | 30.10 Mn |
| Dec 31, 2023 | 47.77 Mn |
| Sep 30, 2023 | 31.34 Mn |
| Jun 30, 2023 | 51.33 Mn |
| Mar 31, 2023 | 83.73 Mn |
| Dec 31, 2022 | 130.78 Mn |
| Sep 30, 2022 | 151.14 Mn |
| Jun 30, 2022 | 191.75 Mn |
| Mar 31, 2022 | 152.99 Mn |
| Dec 31, 2021 | 189.05 Mn |
| Sep 30, 2021 | 195.08 Mn |